$6.97 $0.13 per serving
Product analysis
Double Strength Ginkgo Biloba 120 mg combines ginkgo’s possible attention-related role with eleuthero’s fatigue-related use. Everyday concentration benefits remain uncertain, and missing extract details make preparation comparisons harder.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality33
Ginkgo components are named, but its preparation quality remains uncertain. Eleuthero lacks a specific form or plant-part description, limiting comparisons with other extracts.
Ingredient Transparency65
Both ingredient amounts are stated. Missing ginkgo component proportions and an unspecified eleuthero form prevent a complete preparation comparison.
Value For Money62
The selected serving is inexpensive when considering eleuthero. Value for the ginkgo contribution remains uncertain, so that does not settle the value of the whole combination.
Customer Satisfaction94
Customer feedback is strongly positive across a very large number of ratings. That gives a broad picture of buyer satisfaction, without establishing cognitive effects.
Product Focus58
Two ingredients keep the formula easy to follow. Support for everyday attention and productivity is mixed or limited, despite the clear cognitive theme.
- Format
Capsule - Container
- 50 Capsule(s)
- Per serving
- $0.13
- Also available
Double Strength Ginkgo Biloba 120 mg$10.76- Customer rating
- 4.8 · 38,312 ratings
Goals
Impact
Moderate effect
The 120 mg ginkgo provides the main connection to brain energy processes. The saved evidence supports only a cautious contribution, with no assured routine cognitive improvement for healthy users.
How this product is rated for Brain Health
Ingredient fit80
The formula has a useful focus on relevant ingredients, alongside broader purposes. The counted ingredient amounts reach the saved comparison benchmarks.
Goal fit
The formula has a useful focus on relevant ingredients, alongside broader purposes.
Dose adequacy
The counted ingredient amounts reach the saved comparison benchmarks.
Pathways43
The clearest connection is to brain energy processes, with substantial coverage in the saved findings. One reviewed mechanism has sufficient support; the overall range remains narrow.
Depth
The clearest connection is to brain energy processes, with substantial coverage in the saved findings.
Breadth
One reviewed mechanism has sufficient support; the overall range remains narrow.
Evidence58
Ginkgo provides the strongest evidence among ingredients counted at a meaningful amount. The practical benefit remains dependent on context. The counted ingredients at meaningful amounts match preparations accepted in the saved assessment.
Evidence strength
Ginkgo provides the strongest evidence among ingredients counted at a meaningful amount. The practical benefit remains dependent on context.
Studied preparation
The counted ingredients at meaningful amounts match preparations accepted in the saved assessment.
Formulation logic100
The relevant ingredients can contribute independently or have their required partner. No ingredient conflicts were identified in the saved assessment.
Partner coverage
The relevant ingredients can contribute independently or have their required partner.
Conflicts
No ingredient conflicts were identified in the saved assessment.
Effective doses
1 of 1 relevant ingredients reach the saved meaningful-amount threshold.
Impact
Moderate effect
Ginkgo provides the main preliminary connection to acute attention-speed tasks and cerebral blood-flow mechanisms. Its 120 mg declaration is unidentified, while 250 mg eleuthero adds a stress-fatigue rationale with limited direct cognitive evidence.
How this product is rated for Cognitive Support
Ingredient fit91
Ginkgo and eleuthero give a focused composition with a strong saved exposure match.
Goal fit
Ginkgo and eleuthero give a focused composition with a strong saved exposure match..
Dose adequacy
Ginkgo meets the saved exposure reference; eleuthero contributes a partial match.
Pathways40
Cerebral blood flow is the main area represented in the saved findings. One core area reaches meaningful coverage, giving narrow breadth.
Depth
Cerebral blood flow is the main area represented in the saved findings.
Breadth
One core area reaches meaningful coverage, giving narrow breadth.
Evidence25
Ginkgo supplies the strongest relevant evidence; eleuthero has limited direct cognitive support. The relevant material is not identified as a studied cognitive preparation.
Evidence strength
Ginkgo supplies the strongest relevant evidence; eleuthero has limited direct cognitive support.
Studied preparation
The relevant material is not identified as a studied cognitive preparation.
Formulation logic100
The relevant ingredients can contribute without an additional required partner. All ingredients counted in the saved effective-exposure finding reach its minimum level.
Partner coverage
The saved assessment finds no missing required partner for the relevant ingredients.
Conflicts
No listed cognitive-performance conflict was found in the supplied assessment.
Effective doses
All ingredients counted in the saved effective-exposure finding reach its minimum level.
Impact
Moderate effect
Ginkgo at 120 mg relates to cognitive support, while 250 mg eleuthero is mainly associated with fatigue resilience. Evidence for consistent routine attention benefits is mixed or limited, and eleuthero contributes less strongly at this amount in the saved assessment.
How this product is rated for Mental Focus
Ingredient fit83
The assessed ingredients are closely centered on cognitive support, although the formula is also linked to other goals. The saved dose assessment finds partial support from the declared amounts.
Goal fit
The assessed ingredients are closely centered on cognitive support, although the formula is also linked to other goals.
Dose adequacy
The saved dose assessment finds partial support from the declared amounts.
Pathways44
Support associated with cerebral energy supply is the strongest mechanism in the saved findings. One of the three target mechanisms reaches the saved coverage threshold, so coverage remains concentrated in one area.
Depth
Support associated with cerebral energy supply is the strongest mechanism in the saved findings.
Breadth
One of the three target mechanisms reaches the saved coverage threshold, so coverage remains concentrated in one area.
Evidence62
Ginkgo provides the strongest saved evidence rating here, although attention findings are mixed. The saved assessment recognizes the preparations of all ingredients included at qualifying amounts.
Evidence strength
Ginkgo provides the strongest saved evidence rating here, although attention findings are mixed.
Studied preparation
The saved assessment recognizes the preparations of all ingredients included at qualifying amounts.
Formulation logic100
The saved findings identify no missing required partner for the included ingredients. No configured ingredient conflict was found in the saved assessment. All ingredients included in this finding reach the saved minimum dose threshold.
Partner coverage
The saved findings identify no missing required partner for the included ingredients.
Conflicts
No configured ingredient conflict was found in the saved assessment.
Effective doses
All ingredients included in this finding reach the saved minimum dose threshold.
Impact
Moderate effect
Eleuthero · 250 mgEleuthero · 250 mg
Ginkgo at 120 mg relates to memory and attention, but findings are mixed. Eleuthero at 250 mg is associated with stress and fatigue support, with weaker evidence for routine work performance.
How this product is rated for Productivity Boost
Ingredient fit86
The relevant ingredients are a clear focus of the formula. The assessed amounts come close to the saved comparison benchmarks overall.
Goal fit
The relevant ingredients are a clear focus of the formula.
Dose adequacy
The assessed amounts come close to the saved comparison benchmarks overall.
Pathways13
The strongest assessed area is synaptic plasticity and neuroprotection, with limited coverage. None of the assessed areas reaches the saved threshold for substantial coverage.
Depth
The strongest assessed area is synaptic plasticity and neuroprotection, with limited coverage.
Breadth
None of the assessed areas reaches the saved threshold for substantial coverage.
Evidence42
Ginkgo provides the strongest evidence contribution among the assessed ingredients; its relevance to everyday productivity remains qualified. Preparation matching is partial; Eleuthero. Shared rubric rule. lack a recognized trial-preparation match.
Evidence strength
Ginkgo provides the strongest evidence contribution among the assessed ingredients; its relevance to everyday productivity remains qualified.
Studied preparation
Preparation matching is partial; Eleuthero. Shared rubric rule. lack a recognized trial-preparation match.
Formulation logic100
The assessed ingredients can contribute independently or have their required partner. No configured ingredient conflict was matched in the supplied assessment. All ingredients included in this check reach its minimum amount threshold.
Partner coverage
The assessed ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was matched in the supplied assessment.
Effective doses
All ingredients included in this check reach its minimum amount threshold.
Eleuthero Not classified
No linked studies yet.
Impact
Moderate effect
Whether ginkgo helps everyday vision is unclear. Its connection to the eyes concerns blood flow, but effects depend on the extract and the circumstances in which it's used. The declared amount alone doesn't show that it will improve how clearly you see or your ability to distinguish contrast.
How this product is rated for Eye Health
Ingredient fit60
Ginkgo is the sole ingredient connected with this goal, with uncertainty about everyday visual benefit.
Goal fit
Ginkgo is the only relevant active here; its practical usefulness for routine vision remains uncertain.
Dose adequacy
The serving supplies 120 mg ginkgo; the comparison anchors are 120–240 mg, without guaranteeing an everyday vision benefit.
Pathways40
The connection concerns blood flow in the eyes; an improvement in everyday vision remains uncertain.
Depth
The connection concerns blood flow in the eyes; an improvement in everyday vision remains uncertain.
Breadth
The connection is concentrated on ocular blood flow.
Evidence64
Ginkgo effects are specific to extracts and particular eye conditions; a general everyday vision benefit remains uncertain.
Evidence strength
Ginkgo effects are specific to extracts and particular eye conditions; a general everyday vision benefit remains uncertain.
Studied preparation
The ginkgo form is recognized, but extract-specific effects cannot be generalized to routine vision improvement.
Formulation logic100
No particular ingredient conflict is identified, and no missing partner is identified for the ingredients involved.
Partner coverage
No missing partner is identified for the relevant ingredients.
Conflicts
No particular conflict between the ingredients is identified.
Effective doses
The relevant declared amounts span their comparison ranges; these ranges do not establish a minimum effective dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Ginkgo extract (Ginkgoflavonglycosides, Terpene Lactones) | 120 mg | |
organic Eleuthero | 250 mg |
Ginkgo (Ginkgoflavonglycosides, Terpene Lactones) · 120 mg OverallScore71
Double Strength Ginkgo Biloba 120 mg provides 120 mg of ginkgo leaf extract per serving. The leaf extract has a 50:1 extract ratio and lists 6% terpene lactones, but its flavone percentage is unknown. A ginkgolic acid limit is unknown, and the available information does not establish its value for ginkgo.
How this ingredient is rated
Composition and Label Disclosure42
The leaf extract has a 50:1 extract ratio and lists 6% terpene lactones, but its flavone percentage is unknown. No ginkgolic acid limit is available.
Marker and Preparation Disclosure
The leaf extract has a 50:1 extract ratio and lists 6% terpene lactones, but its flavone percentage is unknown.
Declared Ginkgolic Acid Limit
A ginkgolic acid limit is not available, so the limit cannot be established.
Composition and Label Disclosure100
The serving specifies 120 mg of ginkgo leaf extract.
Individual Preparation Amount Disclosure
The amount and source are stated: 120 mg of ginkgo leaf extract per serving.
Commercial Price and Usability
Ginkgo value is not established here.
Eleuthero · 250 mg OverallScore60
The serving provides 250 mg of Eleuthero at a low cost per serving. The plant part, preparation and eleutheroside content are unspecified.
How this ingredient is rated
Composition and Label Disclosure0
The available information does not specify the plant part, preparation, or eleutheroside content.
Eleutheroside Marker Disclosure
The available information does not specify eleutheroside content or an extract ratio.
Target Plant-Part Identification
The plant part is not specified in the available information.
Composition and Label Disclosure100
The serving lists 250 mg of Eleuthero.
Eleuthero Amount Disclosure
The amount of Eleuthero per serving is stated as 250 mg.
Commercial Price and Usability100
The cost per serving is low.
Selected-Serving Price Comparison
The cost per serving is low.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
- Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
- [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
- Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
- [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
- Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity.
- Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration.
- Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
- Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.